Normal values of insulin-like growth factor I and their clinical utility in adults

被引:37
作者
Strasburger, CJ [1 ]
Bidlingmaier, M [1 ]
Wu, ZD [1 ]
Morrison, KM [1 ]
机构
[1] Univ Munich, Dept Med, Neuroendocrine Unit, D-80336 Munich, Germany
关键词
acromegaly; acid-labile subunit; diagnosis; growth hormone deficiency; insulin-like growth factor I; insulin-like growth factor binding protein 3 monitoring; normative data; safety;
D O I
10.1159/000063484
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The concentration Of circulating insulin-like growth factor I (IGF-I) is a potential marker for growth hormone (GH) deficiency in adults. Indeed, researchers have shown that IGF-I levels are of greater diagnostic value than other possible markers, Such as IGF-binding protein 3 (IGFBP-3) and the acid-labile subunit (ALS). Accurate age-matched normative data are essential to give patient data diagnostic meaning. Such data are assay specific and must exclude those individuals with certain confounding medical conditions. Post-diagnosis, monitoring of IGF-I and IGFBP-3 levels can be used to assess the efficacy and safety of GH replacement therapy. Furthermore, IGF-I levels, and possibly ALS levels, can be used to aid the diagnosis and monitoring of acromegaly. For example, acromegaly can be excluded in patients with normal. IGF-I levels if liver failure and malnutrition/malabsorption are ruled out. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:100 / 105
页数:6
相关论文
共 50 条
  • [41] Insulin-Like Growth Factor I: Pros and Cons of a Bioassay
    Janssen, J. A. M. J. L.
    HORMONE RESEARCH IN PAEDIATRICS, 2011, 76 : 106 - 110
  • [42] Mecasermin (recombinant human insulin-like growth factor I)
    Rosenbloom, Arlan L.
    ADVANCES IN THERAPY, 2009, 26 (01) : 40 - 54
  • [43] DISPOSITION OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR-I IN NORMAL AND HYPOPHYSECTOMIZED RATS
    KIMURA, T
    KANZAKI, Y
    MATSUMOTO, Y
    MANDAI, M
    KUROSAKI, Y
    NAKAYAMA, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1994, 17 (02) : 310 - 315
  • [44] Insulin-like growth factor axis (insulin-like growth factor-I/insulin-like growth factor-binding protein-3) as a prognostic predictor of heart failure: association with adiponectin
    Watanabe, Shin
    Tamura, Toshihiro
    Ono, Koh
    Horiuchi, Hisanori
    Kimura, Takeshi
    Kita, Toru
    Furukawa, Yutaka
    EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (11) : 1214 - 1222
  • [45] In vitro studies of insulin-like growth factor I and bone
    Conover, CA
    GROWTH HORMONE & IGF RESEARCH, 2000, 10 : 107 - 110
  • [46] Growth hormone/insulin-like growth factor I axis in health and disease states: an update on the role of intra-portal insulin
    Yuen, Kevin C. J.
    Hjortebjerg, Rikke
    Ganeshalingam, Ashok Ainkaran
    Clemmons, David R.
    Frystyk, Jan
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [47] Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults
    Yuen, K. C. J.
    Dunger, D. B.
    DIABETES OBESITY & METABOLISM, 2007, 9 (01) : 11 - 22
  • [48] Local Expression of Insulin-Like Growth Factor-I, Insulin-Like Growth Factor-I Receptor, and Estrogen Receptor Alpha in Ovarian Cancer
    An, Yuan
    Cai, Liying
    Wang, Yuguang
    Zhu, Daling
    Guan, Yongmei
    Zheng, Jianhua
    ONKOLOGIE, 2009, 32 (11): : 638 - 644
  • [49] Two chain ''Insulin/Insulin-like Growth Factor-I'' hybrids
    Tang, YH
    Cui, HB
    Feng, YM
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 1996, 28 (05): : 555 - 561
  • [50] Serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in obese children
    Bideci, A
    Cinaz, P
    Hasanoglu, A
    Elbeg, S
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 1997, 10 (03) : 295 - 299